Pfizer Inc.
PFE
$26.27
-$0.05-0.19%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -58.02% | 10.99% | -41.99% |
| Total Depreciation and Amortization | -- | -- | 6.74% | -2.39% | 27.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -305.12% | 18.38% | -146.38% |
| Change in Net Operating Assets | -- | -- | 28.89% | -325.51% | 153.26% |
| Cash from Operations | -- | -- | -199.67% | -85.88% | 43.66% |
| Capital Expenditure | -- | -- | 19.75% | -13.79% | -19.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -651.10% | -66.67% | 6,144.39% |
| Cash from Investing | -- | -- | -868.78% | 175.17% | -603.35% |
| Total Debt Issued | -- | -- | 12,824.05% | 127.37% | -336.61% |
| Total Debt Repaid | -- | -- | -271.75% | 85.92% | 50.84% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -0.52% | -2.58% | 0.00% |
| Other Financing Activities | -- | -- | 67.66% | -6,328.57% | 40.00% |
| Cash from Financing | -- | -- | 1,080.66% | 44.75% | 12.95% |
| Foreign Exchange rate Adjustments | -- | -- | -150.00% | 92.31% | 63.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -72.92% | 301.61% | -79.01% |
